A Study of Quinacrine in Participants With Cutaneous Lupus Erythematosus

NCT07694336 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Lupus Erythematosus (CLE)

Interventions

DRUG: Quinacrine Hydrochloride
OTHER: Placebo

Sponsor

Victoria Werth